---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295712931.md"
description: "During Wednesday's after-market session, several healthcare stocks experienced significant volatility. Gainers included ENvue Medical (up 49.1%), Omeros (up 22.46%), and Bone Biologics (up 13.2%). Conversely, Outlook Therapeutics fell 16.2%, while Valion Bio dropped 14.61%. These movements were largely driven by the release of Q2 earnings reports for companies such as Omeros, RenovoRx, and MaxCyte."
datetime: "2026-08-12T21:06:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295712931.md)
  - [en](https://longbridge.com/en/news/295712931.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295712931.md)
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **ENvue Medical** (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million.
-   **Omeros** (NASDAQ:OMER) stock moved upwards by 22.46% to $16.79. The company's market cap stands at $984.3 million. As per the news, the Q2 earnings report came out today.
-   **Bone Biologics** (NASDAQ:BBLG) stock increased by 13.2% to $0.74. The company's market cap stands at $1.6 million.
-   **Biote** (NASDAQ:BTMD) stock rose 9.85% to $1.56. The market value of their outstanding shares is at $46.7 million.
-   **Redhill Biopharma** (NASDAQ:RDHL) stock moved upwards by 8.32% to $0.64. The company's market cap stands at $3.6 million.
-   **RenovoRx** (NASDAQ:RNXT) stock moved upwards by 7.14% to $1.2. The company's market cap stands at $51.8 million. As per the press release, Q2 earnings came out today.

### Losers

-   **Outlook Therapeutics** (NASDAQ:OTLK) shares fell 16.2% to $0.92 during Wednesday's after-market session. The company's market cap stands at $211.3 million.
-   **Valion Bio** (NASDAQ:VBIO) stock fell 14.61% to $0.19. The market value of their outstanding shares is at $1.2 million.
-   **Modular Medical** (NASDAQ:MODD) stock decreased by 13.05% to $1.8. The company's market cap stands at $10.9 million.
-   **AngioDynamics** (NASDAQ:ANGO) shares fell 11.37% to $13.96. The market value of their outstanding shares is at $650.9 million.
-   **Curis** (NASDAQ:CRIS) stock decreased by 10.78% to $1.49. The market value of their outstanding shares is at $4.8 million.
-   **MaxCyte** (NASDAQ:MXCT) stock fell 9.46% to $1.15. The market value of their outstanding shares is at $132.8 million. The company's, Q2 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md)
- [FEED.US](https://longbridge.com/en/quote/FEED.US.md)
- [BBLG.US](https://longbridge.com/en/quote/BBLG.US.md)
- [OMER.US](https://longbridge.com/en/quote/OMER.US.md)
- [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md)
- [MXCT.US](https://longbridge.com/en/quote/MXCT.US.md)
- [BTMD.US](https://longbridge.com/en/quote/BTMD.US.md)
- [RDHL.US](https://longbridge.com/en/quote/RDHL.US.md)
- [MODD.US](https://longbridge.com/en/quote/MODD.US.md)
- [ANGO.US](https://longbridge.com/en/quote/ANGO.US.md)
- [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md)
- [BBLGW.US](https://longbridge.com/en/quote/BBLGW.US.md)

## Related News & Research

- [OTLK: FDA approval and launch plans for LYTENAVA drive growth prospects amid improved financials](https://longbridge.com/en/news/295929118.md)
- [Omeros Corporation (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/295993093.md)
- [MaxCyte Q2 revenue beats estimates](https://longbridge.com/en/news/295704917.md)
- [MaxCyte (MXCT) Q2 2026 Earnings Call: Guidance Reaffirmed as Genentech Partnership Expands](https://longbridge.com/en/news/295903804.md)
- [Outlook Therapeutics CFO Lawrence Kenyon acquires 101,010 common shares valued at $99,999.9](https://longbridge.com/en/news/295983837.md)